Received Apr 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | N/A | 4BN95 | IM / RA |
Patient received vaccine at age 58 instead of recommended age of 60 years old. No adverse reactions occurred.
N/A
N/A
N/A
N/A